Ørsted (ORSTED) Q4 2023 & Capital Markets Update earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 & Capital Markets Update earnings summary
4 Nov, 2026Executive summary
FY 2023 adjusted EBITDA was DKK 24.0bn, slightly above DKK 20–23bn guidance, despite project and market challenges.
Portfolio reset prioritises higher-value opportunities, reduces execution risk and strengthens the balance-sheet plan.
2030 ambition is 35–38 GW of installed renewable capacity and DKK 39–43bn EBITDA, down from ~50 GW and DKK 50–55bn previously.
Financial highlights
FY 2023 revenue was DKK 79.3bn; EBITDA excluding new partnerships and cancellation fees was DKK 24.0bn, with DKK 4.3bn from partnerships and DKK 9.6bn in cancellation-fee provisions.
Impairments totalled DKK 26.8bn, including DKK 19.9bn for Ocean Wind 1; Ocean Wind impairment and cancellation fees were in line with the Q3 announcement.
ROCE was 12.9% after adjustment for impairment losses and cancellation fees.
Scope 1–3 emissions fell 46%, excluding natural gas sales.
Outlook and guidance
2024 EBITDA guidance is DKK 23–26bn, excluding new partnerships and cancellation fees; higher offshore generation is partly offset by lower merchant prices and German subsidies stepping down.
EBITDA excluding new partnerships and cancellation fees is projected at DKK 30–34bn in 2026 and DKK 39–43bn in 2030; the 2030 target implies 8% CAGR for 2023–2030.
Installed renewable capacity is projected to rise from 15.7 GW in 2023 to ~23 GW by 2026 and 35–38 GW by 2030.
2024–2030 targets include ~14% average ROCE, DKK 270bn gross investment and 150–300 bps lifecycle spread to WACC at bid or FID.
Fixed costs are targeted to fall DKK 1bn by 2026 vs. 2023 on a like-for-like basis; plans include reducing 600–800 positions globally.
Latest events from Ørsted
- Adjusted EBITDA grew, but US impairments drove a Q3 loss as offshore projects advanced.ORSTED
Q3 2026 - Adjusted EBITDA beat guidance as the reset plan prioritizes value-led growth and balance-sheet resilience.ORSTED
Q4 2023 (Media) - 2023 EBITDA guidance of DKK 20bn–23bn rests on renewable recovery amid hedge and project risks.ORSTED
Guidance - FY 2026 EBITDA guidance tops DKK 28bn as higher US rates raise impairment sensitivity.ORSTED
Pre-Close Call Presentation - H1 2026 EBITDA up, revenue rises 28%, profit drops on impairments; 2026 outlook reaffirmed.ORSTED
Q2 2026 - EBITDA set to exceed DKK 28 bn in 2026, with major divestments and improved ROCE outlook.ORSTED
Pre-Close Call Presentation - EBITDA to surpass DKK 28 bn in 2026, with major investments and US-driven impairments.ORSTED
Pre-Close Call Presentation - Key AGM resolutions passed; offshore wind strategy continued amid U.S. delays.ORSTED
AGM 2026 - Value-focused refocus, U.S. impairments and no FY2024 dividend; key AGM items approved.ORSTED
AGM 2025